PMDA inspection

Eli Lilly and Company

PMDA inspection 5130608014463 · USA · Suitable

Key facts

Control number 5130608014463
Manufacturing site Eli Lilly and Company
Location Lilly Corporate Center, Indianapolis, Indiana 46285, USA
Country USA
Product type Pharmaceuticals
Application type Regular
Inspection method Remote
Inspection month Oct 1, 2024
Result Suitable
Result notified Oct 31, 2024
PMDA registration AG30400327

About PMDA GMP inspections (Japan)

Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Browse all PMDA GMP inspections (Japan)